لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Sun DP; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.; Department of Hematology, Jining No. 1 People's Hospital, Jining, 272011, China., Chen WM; Department of Oncology, Jining No. 1 People's Hospital, Jining, 272011, China., Wang L; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.; Pukou CLL Center, Nanjing, 210000, China., Wang Z; Department of Pathology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China., Liang JH; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.; Pukou CLL Center, Nanjing, 210000, China., Zhu HY; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.; Pukou CLL Center, Nanjing, 210000, China., Fan L; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.; Pukou CLL Center, Nanjing, 210000, China., Wu YJ; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.; Pukou CLL Center, Nanjing, 210000, China., Xu W; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China. xuwei10000@hotmail.com.; Pukou CLL Center, Nanjing, 210000, China. xuwei10000@hotmail.com., Li JY; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China. lijianyonglm@126.com.; Pukou CLL Center, Nanjing, 210000, China. lijianyonglm@126.com.

المصدر: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2021 Jul; Vol. 147 (7), pp. 2107-2115. Date of Electronic Publication: 2021 Feb 05.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Autoimmune Diseases/*immunology , Castleman Disease/*complications , Multiple Organ Failure/*etiology, Adolescent ; Adult ; Aged ; Aged, 80 and over ; Autoimmune Diseases/epidemiology ; Autoimmune Diseases/pathology ; China/epidemiology ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Multiple Organ Failure/pathology ; Prognosis ; Retrospective Studies ; Young Adult

المؤلفون: Xu DM; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, 210029, China., Liang JH; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, 210029, China., Wang L; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, 210029, China., Zhu HY; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, 210029, China., Xia Y; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, 210029, China., Fan L; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, 210029, China., Li JY; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, 210029, China., Xu W; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China. xuwei10000@hotmail.com.; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China. xuwei10000@hotmail.com.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, 210029, China. xuwei10000@hotmail.com.

المصدر: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2020 Apr; Vol. 146 (4), pp. 1003-1009. Date of Electronic Publication: 2020 Jan 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, Mantle-Cell/*blood , Vitamin D/*analogs & derivatives , Vitamin D Deficiency/*blood, Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Biomarkers, Tumor/blood ; Female ; Humans ; Lymphoma, Mantle-Cell/drug therapy ; Male ; Middle Aged ; Predictive Value of Tests ; Prognosis ; Progression-Free Survival ; Survival Rate ; Vitamin D/blood

المؤلفون: Zhang XY; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, 210029, China., Liang JH; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, 210029, China., Wang L; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, 210029, China., Zhu HY; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, 210029, China., Wu W; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, 210029, China., Cao L; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, 210029, China., Fan L; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, 210029, China., Li JY; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, 210029, China., Xu W; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China. xuwei10000@hotmail.com.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, 210029, China. xuwei10000@hotmail.com.

المصدر: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2019 Jan; Vol. 145 (1), pp. 117-127. Date of Electronic Publication: 2018 Oct 16.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*administration & dosage , Lymphoma, Large B-Cell, Diffuse/*drug therapy, Adolescent ; Adult ; Age Factors ; Aged ; Aged, 80 and over ; Antibodies, Monoclonal, Murine-Derived/administration & dosage ; Antibodies, Monoclonal, Murine-Derived/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Cyclophosphamide/administration & dosage ; Cyclophosphamide/adverse effects ; Disease-Free Survival ; Doxorubicin/administration & dosage ; Doxorubicin/adverse effects ; Etoposide/administration & dosage ; Etoposide/adverse effects ; Female ; Humans ; Infusions, Intravenous ; Lymphoma, Large B-Cell, Diffuse/metabolism ; Male ; Middle Aged ; Phenotype ; Prednisone/administration & dosage ; Prednisone/adverse effects ; Prognosis ; Proto-Oncogene Proteins c-bcl-2/metabolism ; Proto-Oncogene Proteins c-myc/metabolism ; Remission Induction ; Retrospective Studies ; Rituximab ; Treatment Outcome ; Vincristine/administration & dosage ; Vincristine/adverse effects

SCR Protocol: EPOCH protocol

المؤلفون: Liang JH; Department of Hematology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, 210029, China., Gao R; Department of Endocrinology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China., Dai JC; Department of Epidemiology and Biostatistics, Nanjing Medical University School of Public Health, Nanjing, 210029, China., Gale RP; Division of Experimental Medicine, Department of Medicine, Haematology Research Centre, Imperial College London, London, UK., Li W; Department of Hematology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, 210029, China., Fan L; Department of Hematology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, 210029, China., Hu ZB; Department of Epidemiology and Biostatistics, Nanjing Medical University School of Public Health, Nanjing, 210029, China., Xu W; Department of Hematology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China. xuwei10000@hotmail.com.; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China. xuwei10000@hotmail.com.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, 210029, China. xuwei10000@hotmail.com., Li JY; Department of Hematology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China. lijianyonglm@medmail.com.cn.; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China. lijianyonglm@medmail.com.cn.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, 210029, China. lijianyonglm@medmail.com.cn.

المصدر: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2018 Jul; Vol. 144 (7), pp. 1309-1315. Date of Electronic Publication: 2018 May 14.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Hepatitis B/*complications , Leukemia, Lymphocytic, Chronic, B-Cell/*virology, Adult ; Aged ; China ; Cohort Studies ; Female ; Humans ; Kaplan-Meier Estimate ; Leukemia, Lymphocytic, Chronic, B-Cell/mortality ; Male ; Middle Aged ; Prognosis ; Proportional Hazards Models ; Risk Factors

المؤلفون: Wang WT; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, 210029, China., Zhu HY; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, 210029, China., Wu YJ; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, 210029, China., Xia Y; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, 210029, China., Wu JZ; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, 210029, China., Wu W; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, 210029, China., Liang JH; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, 210029, China., Wang L; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, 210029, China., Fan L; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, 210029, China., Li JY; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, 210029, China., Xu W; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China. xuwei10000@hotmail.com.; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China. xuwei10000@hotmail.com.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, 210029, China. xuwei10000@hotmail.com.

المصدر: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2018 Mar; Vol. 144 (3), pp. 449-457. Date of Electronic Publication: 2018 Jan 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Killer Cells, Natural/*pathology , Leukemia, Lymphocytic, Chronic, B-Cell/*diagnosis , Leukemia, Lymphocytic, Chronic, B-Cell/*immunology, Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Leukemia, Lymphocytic, Chronic, B-Cell/mortality ; Leukemia, Lymphocytic, Chronic, B-Cell/pathology ; Lymphocyte Count ; Male ; Middle Aged ; Prognosis ; Retrospective Studies ; Survival Analysis

المؤلفون: Gong MF; Department of Neuropharmacology and Novel Drug Discovery, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China.; Department of Behavioral Medicine and Psychiatry, Blanchette Rockefeller Neurosciences Institute, West Virginia University Health Sciences Center, Morgantown, WV, 26506, USA.; Department of Physiology and Pharmacology, Blanchette Rockefeller Neurosciences Institute, West Virginia University Health Sciences Center, Morgantown, WV, 26506, USA., Wen RT; Department of Behavioral Medicine and Psychiatry, Blanchette Rockefeller Neurosciences Institute, West Virginia University Health Sciences Center, Morgantown, WV, 26506, USA.; Department of Physiology and Pharmacology, Blanchette Rockefeller Neurosciences Institute, West Virginia University Health Sciences Center, Morgantown, WV, 26506, USA.; Department of Pharmacy, Peking University People's Hospital, Beijing, 100044, China., Xu Y; Department of Behavioral Medicine and Psychiatry, Blanchette Rockefeller Neurosciences Institute, West Virginia University Health Sciences Center, Morgantown, WV, 26506, USA.; Department of Physiology and Pharmacology, Blanchette Rockefeller Neurosciences Institute, West Virginia University Health Sciences Center, Morgantown, WV, 26506, USA.; Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, The State University of New York at Buffalo, Buffalo, NY, 14214, USA., Pan JC; Brain Institute, School of Pharmacy, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China., Fei N; Brain Institute, School of Pharmacy, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China., Zhou YM; Institute of Pharmacology, Taishan Medical University, Taian, Shandong, 271016, China., Xu JP; Department of Neuropharmacology and Novel Drug Discovery, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China. jpx@smu.edu.cn., Liang JH; Department of Molecular and Cellular Pharmacology, Peking University School of Pharmaceutical Sciences, Beijing, 100191, China. liangjh@bjmu.edu.cn., Zhang HT; Department of Behavioral Medicine and Psychiatry, Blanchette Rockefeller Neurosciences Institute, West Virginia University Health Sciences Center, Morgantown, WV, 26506, USA. hzhang@hsc.wvu.edu.; Department of Physiology and Pharmacology, Blanchette Rockefeller Neurosciences Institute, West Virginia University Health Sciences Center, Morgantown, WV, 26506, USA. hzhang@hsc.wvu.edu.; Institute of Pharmacology, Taishan Medical University, Taian, Shandong, 271016, China. hzhang@hsc.wvu.edu.

المصدر: Psychopharmacology [Psychopharmacology (Berl)] 2017 Oct; Vol. 234 (20), pp. 3143-3151. Date of Electronic Publication: 2017 Jul 27.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7608025 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-2072 (Electronic) Linking ISSN: 00333158 NLM ISO Abbreviation: Psychopharmacology (Berl) Subsets: MEDLINE

مواضيع طبية MeSH: Alcohol Abstinence/*psychology , Anxiety/*psychology , Depression/*psychology , Ethanol/*toxicity , Phosphodiesterase 4 Inhibitors/*therapeutic use , Rolipram/*therapeutic use, Alcohol Drinking/drug therapy ; Alcohol Drinking/psychology ; Animals ; Anti-Anxiety Agents/pharmacology ; Anti-Anxiety Agents/therapeutic use ; Antidepressive Agents/pharmacology ; Anxiety/chemically induced ; Anxiety/drug therapy ; Depression/chemically induced ; Depression/drug therapy ; Dose-Response Relationship, Drug ; Ethanol/administration & dosage ; Male ; Mice ; Mice, Inbred C57BL ; Phosphodiesterase 4 Inhibitors/pharmacology ; Random Allocation ; Rats ; Rodentia ; Rolipram/pharmacology ; Substance Withdrawal Syndrome/drug therapy ; Substance Withdrawal Syndrome/psychology

المؤلفون: Qin WJ; Department of Pharmacy, China-Japan Friendship Hospital, Beijing, 100029, China., Wang YT; Department of Pharmacy, Cancer Hospital/Institute, Chinese Academy of Medical Sciences, Beijing, China., Li PM; Department of Pharmacy, China-Japan Friendship Hospital, Beijing, 100029, China., Wang XX; Department of Pharmacy, China-Japan Friendship Hospital, Beijing, 100029, China., Li JX; Department of Pharmacology and Toxicology, School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA., Noori HR; Institute of Psychopharmacology, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Bernardi RE; Institute of Psychopharmacology, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Liang JH; Department of Molecular and Cellular Pharmacology, Peking University School of Pharmaceutical Sciences, Beijing, 100191, China. liangjh@bjmu.edu.cn., Zhang XL; Department of Pharmacy, China-Japan Friendship Hospital, Beijing, 100029, China. lpandwpandmemory@126.com.

المصدر: Psychopharmacology [Psychopharmacology (Berl)] 2016 Apr; Vol. 233 (7), pp. 1147-55. Date of Electronic Publication: 2016 Jan 04.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7608025 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-2072 (Electronic) Linking ISSN: 00333158 NLM ISO Abbreviation: Psychopharmacology (Berl) Subsets: MEDLINE

مواضيع طبية MeSH: Morphine/*pharmacology , Motor Activity/*drug effects , Nucleus Accumbens/*drug effects, Animals ; Behavior, Animal/drug effects ; Cues ; Drug-Seeking Behavior/drug effects ; HSP72 Heat-Shock Proteins/metabolism ; Hyperkinesis/metabolism ; Male ; Mice ; Nucleus Accumbens/metabolism ; Time Factors

المؤلفون: Tu ML; Department of Respiratory Medicine, Yunyang Medical College, Taihe Hospital, Hubei, China., Wang HQ, Chen LJ, Lu JC, Jiang F, Liang JH, Xu DG, Li DS

المصدر: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2009 Nov; Vol. 135 (11), pp. 1543-50. Date of Electronic Publication: 2009 Jun 02.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Endothelial Cells/*physiology , Lung Neoplasms/*blood supply , Neovascularization, Pathologic/*etiology , Proto-Oncogene Proteins c-akt/*physiology, Apoptosis ; Cell Movement ; Cell Survival ; Cells, Cultured ; Culture Media, Conditioned ; Humans ; Lung Neoplasms/pathology ; Phosphatidylinositol 3-Kinases/physiology ; RNA, Small Interfering/genetics

المؤلفون: Liang JH; Department of Neuropharmacology, National Institute on Drug Dependence, Peking University, 38 Xueyuan Road, Beijing 100083, People's Republic of China. liangjh@hotmail.com, Wang K, Sun HL, Han R

المصدر: Psychopharmacology [Psychopharmacology (Berl)] 2006 Mar; Vol. 185 (1), pp. 1-10. Date of Electronic Publication: 2006 Jan 24.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7608025 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0033-3158 (Print) Linking ISSN: 00333158 NLM ISO Abbreviation: Psychopharmacology (Berl) Subsets: MEDLINE

مواضيع طبية MeSH: Central Nervous System Stimulants/*pharmacology , Methamphetamine/*pharmacology , Motor Activity/*drug effects , Narcotics/*pharmacology , Tramadol/*pharmacology, Animals ; Drug Synergism ; Male ; Mice ; Models, Animal